Youssef El Zein insider trades: Aceragen (ACGN) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Youssef reports to the SEC
Open-market buys and sales
22 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Jul 13, 2023 | ACGN | ↓ Sell | 5,818 | $1.56 | $9K | Indirect | Jul 19, 2023 (6d) |
| May 17, 2023 | ACGN | ↑ Buy | 26,965 | $1.42 | $38K | Indirect | Jul 19, 2023 (63d) |
| Mar 18, 2021 | IDRA | ↓ Sell | 1,376,039 | $1.80 | $2.5M | Indirect | Mar 31, 2021 (13d) |
| Mar 18, 2021 | IDRA | ↓ Sell | 323,726 | $1.80 | $582K | By Pillar Pharmaceuticals 6, L.P. | Mar 31, 2021 (13d) |
| Dec 11, 2020 | IDRA | ↑ Buy | 69,941 | $1.82 | $127K | Indirect | Dec 15, 2020 (4d) |
| Jul 13, 2020 | IDRA | ↑ Buy | 749,993 | $1.72 | $1.3M | Indirect | Jul 15, 2020 (2d) |
| Apr 7, 2020 | IDRA | ↑ Buy | 3,039,514 | $1.52 | $4.6M | Indirect | Apr 9, 2020 (2d) |
| Jan 29, 2020 | IDRA | ↓ Sell | 44,782 | $1.77 | $79K | Indirect | Feb 26, 2020 (28d) |
| Nov 8, 2019 | IDRA | ↓ Sell | 119,000 | $2.49 | $296K | Indirect | Nov 8, 2019 (0d) |
| May 1, 2017 | IDRA | ↓ Sell10b5-1 | 450,815 | $2.26 | $1.0M | Indirect | May 3, 2017 (2d) |
| Apr 25, 2017 | IDRA | ↓ Sell10b5-1 | 1,328,422 | $2.29 | $3.0M | Indirect | Apr 26, 2017 (1d) |
| Oct 3, 2016 | IDRA | ↑ Buy | 4,228 | $2.56 | $11K | Direct | Oct 5, 2016 (2d) |
| Dec 16, 2014 | IDRA | ↓ Sell | 100,000 | $3.68 | $368K | Direct | Dec 16, 2014 (0d) |
| Dec 1, 2010 | IDRA | ↑ Buy | 7,000 | $2.52 | $18K | Direct | Dec 3, 2010 (2d) |
| Nov 12, 2010 | IDRA | ↑ Buy | 25,029 | $2.82 | $71K | Direct | Nov 15, 2010 (3d) |
| Nov 10, 2010 | IDRA | ↑ Buy | 13,000 | $2.75 | $36K | Direct | Nov 12, 2010 (2d) |
| Nov 9, 2010 | IDRA | ↑ Buy | 29,000 | $2.77 | $80K | Direct | Nov 10, 2010 (1d) |
| Jun 11, 2010 | IDRA | ↑ Buy | 6,000 | $3.61 | $22K | Direct | Jun 14, 2010 (3d) |
| Jun 10, 2010 | IDRA | ↑ Buy | 3,000 | $3.24 | $10K | Direct | Jun 11, 2010 (1d) |
| Mar 16, 2009 | IDRA | ↓ Sell | 44,483 | $5.62 | $250K | Direct | Mar 18, 2009 (2d) |
| Jan 14, 2009 | IDRA | ↓ Sell | 34,100 | $8.42 | $287K | Direct | Jan 14, 2009 (0d) |
| Dec 22, 2008 | IDRA | ↓ Sell | 8,400 | $8.25 | $69K | Direct | Dec 24, 2008 (2d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About Youssef El Zein's insider trades
Youssef El Zein is a 10% owner of Aceragen (ACGN). Since Dec 22, 2008, Youssef has reported 11 open-market purchases worth $6.3M and 11 sales worth $8.5M on SEC Form 4. There have been no open-market trades in the last 12 months.
2 sales (48% of the value sold) were made under a Rule 10b5-1 trading plan, which is set up months in advance and runs on a schedule, so they say little about how the insider sees the stock today.
Their filings also include grants and awards (41 filings), option exercises (20 filings), other transactions (10 filings), conversions (3 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every ACGN insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.